1 Correction to: Clin Pharmacokinet (2018) 57:1493–1528 https://doi.org/10.1007/s40262-018-0664-3
Page 1517, Section 16.1, para 1, lines 1–3 which previously read:
The pharmacokinetics of CRP was tested in small short-term studies in both healthy volunteers and in subjects with schizophrenia, with similar results [242].
Should read:
The pharmacokinetics of CRP was tested in small short-term studies in healthy volunteers [235] and also in subjects with schizophrenia [242], with similar results.
Page 1517, Section 16.1, para 1, lines 4–6 which previously read:
Cariprazine is rapidly absorbed, reaching peak concentrations between 3 and 4 h after oral dosing in healthy subjects.
Should read:
Cariprazine reached peak plasma concentrations between 3 and 4 h after oral dosing in healthy subjects.
Page 1517, Section 16.1, para 2, lines 1–5 which previously read:
Its pharmacokinetics were linear in terms of AUC but maximum concentrations were more than proportional within the dose range from 3 to 5 mg in healthy subjects. Mean half-life was 2–5 days (1.5–12.5 mg/day) in the subjects with schizophrenia [242].
Should read:
Its pharmacokinetics were linear in terms of AUC but maximum concentrations were more than proportional within the single dose range from 0.5 to 2.5 mg in healthy subjects. Mean half-life was 2–5 days (1.5–12.5 mg/day) in the subjects with schizophrenia [235].
Page 1518, Section 16.1, para 2, lines 8–11 which previously read:
Additionally, the mean concentrations of DCRP and DDCRP were approximately 30 and 40% in the patients, respectively, of CRP concentrations by the end of 12 weeks of treatment [242].
Should read:
Additionally, the mean concentrations of DCRP and DDCRP were approximately 30 and 400% in the patients, respectively, of CRP concentrations by the end of 12 weeks of treatment [242].
Page 1518, Table 8, column 1, row 2, which previously read:
Actavis 2015 [243]
Should read:
Actavis 2015 [242]
Page 1518, Table 8, column 2, row 2, which previously read:
6
Should read:
8
Page 1518, Table 8, column 6, row 3, which previously read:
32–49
Should read:
10–22.7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mauri, M.C., Paletta, S., Di Pace, C. et al. Correction to: Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. Clin Pharmacokinet 58, 1219–1220 (2019). https://doi.org/10.1007/s40262-019-00797-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-019-00797-7